PortfoliosLab logoPortfoliosLab logo
Phibro Animal Health Corporation (PAHC)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US71742Q1067
CUSIP
71742Q106
IPO Date
Apr 11, 2014

Highlights

Market Cap
$2.27B
Enterprise Value
$2.81B
EPS (TTM)
$2.25
PE Ratio
24.53
PEG Ratio
0.06
Total Revenue (TTM)
$1.46B
Gross Profit (TTM)
$467.02M
EBITDA (TTM)
$209.00M
Year Range
$16.16 - $57.62
Target Price
$34.00
ROA (TTM)
6.55%
ROE (TTM)
27.71%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Phibro Animal Health Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Phibro Animal Health Corporation (PAHC) has returned 48.39% so far this year and 162.39% over the past 12 months. Over the last ten years, PAHC has returned 9.53% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Phibro Animal Health Corporation

1D
3.67%
1M
1.55%
YTD
48.39%
6M
37.39%
1Y
162.39%
3Y*
57.25%
5Y*
20.22%
10Y*
9.53%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 11, 2014, PAHC's average daily return is +0.08%, while the average monthly return is +1.63%. At this rate, your investment would double in approximately 3.6 years.

Historically, 60% of months were positive and 40% were negative. The best month was Aug 2025 with a return of +39.9%, while the worst month was Aug 2019 at -33.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, PAHC closed higher 50% of trading days. The best single day was Apr 29, 2024 with a return of +31.8%, while the worst single day was Aug 28, 2019 at -31.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20267.47%35.97%1.55%48.39%
20253.86%4.26%-5.60%-12.87%31.22%5.11%3.76%39.89%9.50%3.95%-0.16%-10.79%80.76%
2024-6.65%19.61%0.88%29.16%5.57%-4.21%12.58%11.23%7.89%2.66%1.60%-10.14%86.30%
202314.84%2.79%-2.48%1.57%-14.52%3.95%5.69%-3.66%-7.70%-14.49%-11.15%20.75%-10.42%
2022-5.48%10.36%-5.81%-9.82%7.44%-0.42%2.30%-24.32%-9.52%10.53%-15.36%8.94%-32.33%
20216.80%4.00%13.72%0.49%14.97%2.89%-18.04%3.14%-11.32%1.86%-10.23%4.24%7.28%

Benchmark Metrics

Phibro Animal Health Corporation has an annualized alpha of 10.46%, beta of 0.91, and R² of 0.14 versus S&P 500 Index. Calculated based on daily prices since April 14, 2014.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (90.90%) than losses (82.84%) — typical of diversified or defensive assets.
  • R² of 0.14 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
10.46%
Beta
0.91
0.14
Upside Capture
90.90%
Downside Capture
82.84%

Return for Risk

Risk / Return Rank

PAHC ranks 96 for risk / return — in the top 96% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


PAHC Risk / Return Rank: 9696
Overall Rank
PAHC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
PAHC Sortino Ratio Rank: 9797
Sortino Ratio Rank
PAHC Omega Ratio Rank: 9494
Omega Ratio Rank
PAHC Calmar Ratio Rank: 9696
Calmar Ratio Rank
PAHC Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and compare them to a chosen benchmark (S&P 500 Index).


PAHCBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

3.09

0.90

+2.19

Sortino ratio

Return per unit of downside risk

3.96

1.39

+2.57

Omega ratio

Gain probability vs. loss probability

1.48

1.21

+0.27

Calmar ratio

Return relative to maximum drawdown

6.51

1.40

+5.11

Martin ratio

Return relative to average drawdown

17.67

6.61

+11.06

Explore PAHC risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Phibro Animal Health Corporation provided a 0.87% dividend yield over the last twelve months, with an annual payout of $0.48 per share. The company has been increasing its dividends for 11 consecutive years.


1.00%1.50%2.00%2.50%3.00%3.50%4.00%4.50%$0.00$0.10$0.20$0.30$0.40$0.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.48$0.42$0.40$0.40$0.40

Dividend yield

0.87%1.28%2.29%4.15%3.58%2.35%2.47%1.93%1.31%1.19%1.37%1.33%

Monthly Dividends

The table displays the monthly dividend distributions for Phibro Animal Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.12$0.12
2025$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2024$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2023$0.00$0.12$0.00$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2022$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.00$0.12$0.00$0.12$0.00$0.48
2021$0.00$0.00$0.12$0.00$0.00$0.12$0.00$0.12$0.00$0.00$0.12$0.00$0.48

Dividend Yield & Payout


Dividend Yield

Phibro Animal Health Corporation has a dividend yield of 0.87%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Phibro Animal Health Corporation has a payout ratio of 21.12%, which is below the market average. This means Phibro Animal Health Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Phibro Animal Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Phibro Animal Health Corporation was 79.62%, occurring on Nov 10, 2023. Recovery took 500 trading sessions.

The current Phibro Animal Health Corporation drawdown is 2.98%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.62%Aug 28, 20181311Nov 10, 2023500Nov 10, 20251811
-54.8%Aug 12, 2015193May 17, 2016305Aug 2, 2017498
-21.85%Jun 12, 201440Aug 7, 201445Oct 10, 201485
-19.03%Aug 18, 2017117Feb 5, 201819Mar 5, 2018136
-18.5%Nov 11, 202528Dec 19, 202531Feb 5, 202659

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Phibro Animal Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Phibro Animal Health Corporation is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PAHC, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/E ratio of 24.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PAHC compared to other companies in the Drug Manufacturers - Specialty & Generic industry. PAHC currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PAHC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PAHC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, PAHC has a P/B value of 6.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items